Value-based care will continue to bring costs to the forefront of healthcare, especially as it pertains to finding ways to truncate costs without comprising patient care and satisfaction. With this shift, more medical schools are teaching students to consider healthcare…
The Latest
Cleveland, Ohio-based KeyCorp raised its fiscal year 2016 earnings-per-share estimate for Nashville, Tenn.-based Surgery Partners' shares, according to The Cerbat Gem.
The New Lenox (Ill.) Village Board gave Silver Cross Hospital in New Lenox approval to build its ASC, according to The Herald News.
While the uninsured rate in America reaches historic lows, payer departures from ACA marketplaces are complicating the law's promise to increase access to healthcare for all. At least 1.4 million people across 32 states will lose their current ACA plans…
Jeffrey G. Priest, MD, has been recognized by Continental Who's Who.
New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma. Kanuma, or sebelipase alfa, is a drug treatment for lysosomal acid lipase deficiency.
New York-based Intercept Pharmaceuticals has released data from three studies related to the Phase 3 POISE trial of Ocaliva. The POISE trial tested daily Ocaliva treatment in patients with primary biliary cholangitis with an inadequate therapeutic response to ursodeoxycholic acid.
Richard Dumois, MD, is a gastroenterologist at Orlando, Fla.-based Central Florida Gastroenterology.
The Woodlands, Texas-based McKesson Specialty Health is launching its in-office dispensing solution in local rheumatology and gastroenterology practices.
Is the patient reported outcomes measurement information system implemented by the Bethesda, Md.-based National Institutes of Health producing better patient outcomes than traditional measures? A study in The American Journal of Gastroenterology found out.